Skip to main content

Table 2 Serum indices from nude mice bearing a BxPC-3 xenograft that were treated orally by gavage with either the vehicle control or DFX (120, 160, or 200 mg/kg) every second day (three treatments per week) for 21 days

From: Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo

 

Units

Treatment groups

Vehicle control

Deferasirox

120 mg/kg

160 mg/kg

200 mg/kg

Ferritin

ng/ml

18.3 ± 1.9

20.6 ± 2.9

8.6 ± 1.4*

9.8 ± 1.5*

Total protein

g/dl

5.0 ± 0.3

5.4 ± 0.3

5.3 ± 0.4

5.3 ± 0.3

Albumin

g/dl

3.2 ± 0.2

3.3 ± 0.1

3.4 ± 0.1

3.4 ± 0.1

Aspartate aminotransferase

U/l

89.2 ± 15.8

106.2 ± 32.6

155.2 ± 97.9

146 ± 58.9

Alanine transaminase

U/l

23.6 ± 1.9

29.2 ± 8.2

28.4 ± 9.6

28.8 ± 7.2

Lactate dehydrogenase

U/l

243.6 ± 37.9

242.6 ± 18.2

243.8 ± 23.1

243.6 ± 21.7

Blood urea nitrogen

mg/dl

560.6 ± 112.7

578.2 ± 65.5

669 ± 43.9

689.8 ± 101.9

Creatinine

mg/dl

17.6 ± 1.2

14.2 ± 2.1

14.4 ± 0.6

15.8 ± 1.3

  1. *p <0.05 vs. control